Predictive diagnosis of endometrial hyperplasia and personalized therapeutic strategy in women of fertile age
Open Access
- 6 December 2013
- journal article
- Published by Springer Nature in EPMA Journal
- Vol. 4 (1) , 24
Abstract
Introduction: Endometrial hyperplasia has a high risk for malignant transformation and relapses; existing mini-invasive treatments may lead to irrevocable endometrium destruction. The aims were to analyze receptor systems in endometrial hyperplasia, to evaluate the capabilities of ultrasonography, sonoelastography for diagnosis and treatment control, and to develop treatment algorithm. Materials and methods: We included 313 women (20–45 years), assessed into the following: group 1 (n = 112) with glandular cystic hyperplasia, group 2 (n = 98) endometrial polyps, and group 3 (n = 103) atypical hyperplasia; and 82 controls who have undergone hysteroscopy before in vitro fertilization in tubal origin infertility were also included. Patients underwent clinical examination, transvaginal ultrasound, immunohistochemical study, and hormonal therapy/hysteroresectoscopy. Results: In patients with glandular hyperplasia, we registered increase of endometrium estrogen receptors (75.6% in the epithelium and 30.9% in the stroma; in controls, 43.3% and 29.6%, respectively); in polyps, there was a significant estrogen receptor increase in the stroma (48.2% vs 29.6% in controls), and in atypical hyperplasia, progesterone receptors significantly increased in the stroma. Ki-67 increased (40% to 50%) in the epithelium without changes in the stroma. Ultrasound has a sensitivity of 96% and a specificity of 85% for early detection of endometrial pathology and prediction outcome of intervention, and sonoelastography has a sensitivity of 91% and a specificity of 83% for polyp diagnosis. Personalized treatment was effective in 88.8%, relapse was diagnosed in 11.2% after 6 months, and conservative treatment of atypical hyperplasia was effective in 45%: in 25.8%, ablative hysteroresectoscopy was performed, while in 22.6% with comorbidities, hystero/oophorectomies were performed. Conclusions: The evaluation of receptor status with ultrasound data in patients with endometrial hyperplasia allows for a clear definition of the treatment policy, avoidance of relapse, treatment optimization, and observation of such patients.Keywords
This publication has 73 references indexed in Scilit:
- Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiologyEPMA Journal, 2013
- Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?EPMA Journal, 2013
- Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicineEPMA Journal, 2013
- General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised MedicineEPMA Journal, 2012
- Evidence-based pain management: is the concept of integrative medicine applicable?EPMA Journal, 2012
- Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measuresEPMA Journal, 2010
- Genetic Algorithm for Solving the Problem of an Optimum Regression Model Construction as a Discrete Optimization ProblemJournal of Long-Term Effects of Medical Implants, 2008
- Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometriumEuropean Journal of Cancer, 2000
- Apoptosis, bcl-2 Expression, and Proliferation in Benign and Malignant Endometrial Epithelium: An Approach Using Multiparameter Flow CytometryGynecologic Oncology, 2000
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995